US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
07

0775.HK

Stock CK Life Sciences Int'l., (Holdings) Inc.
$0.56000

Hong Kong Stock Exchange · Healthcare · HK

Sharia status
NOT COMPLIANT
Per In-house ratio engine · assessed 2026-08-27
HTR non-permissible income 0.39%
🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

CK Life Sciences Int'l., (Holdings) Inc. (0775.HK) is currently considered not halal (non-compliant), per In-house ratio engine (last assessed 2026-08-27). See the full ratio breakdown and business-activity screen below for the reasoning.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

Market & analysts
Institutional own.
0.6%
of shares
NON-COMPLIANT
Sharia compliance
0.39%
Non-permissible income — HTR, from filings (2025-12-31)
0.6%
Institutional ownership

🕌 In-house Compliance Research

Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2025-12-31. 0775.HK files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.

Business activity: cleared (no excluded categories detected)

AAOIFI Fail

RatioValueThresholdResult
Interest-bearing debt 120.94% 30.00% Fail
Interest-bearing investments 10.11% 30.00% Pass
Non-permissible income 0.39% 5.00% Pass

Usmani Fail

RatioValueThresholdResult
Interest-bearing debt 60.95% 33.00% Fail
Interest-bearing investments 5.09% 33.00% Pass
Non-liquid assets 86.74% at least 20.00% Pass
Non-permissible income 0.39% 5.00% Pass

MSCI Fail

RatioValueThresholdResult
Interest-bearing debt 60.95% 33.33% Fail
Cash + interest-bearing securities 5.09% 33.33% Pass
Accounts receivable 13.26% 33.33% Pass
Non-permissible income 0.39% 5.00% Pass

FTSE Fail

RatioValueThresholdResult
Interest-bearing debt 60.95% 33.33% Fail
Cash + interest-bearing securities 5.09% 33.33% Pass
Accounts receivable 13.26% 50.00% Pass
Non-permissible income 0.39% 5.00% Pass

Dow Jones Islamic Market Fail

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 97.70% 33.00% Fail
Cash + interest-bearing securities 8.17% 33.00% Pass
Accounts receivable 13.09% 33.00% Pass
Non-permissible income 0.39% 5.00% Pass

S&P Shariah Fail

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 106.87% 33.00% Fail
Cash + interest-bearing securities 8.93% 49.00% Pass
Accounts receivable 14.32% 49.00% Pass
Non-permissible income 0.39% 5.00% Pass

MSCI M-Series Fail

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 106.87% 33.33% Fail
Cash + interest-bearing securities 8.93% 33.33% Pass
Accounts receivable 23.26% 49.00% Pass
Non-permissible income 0.39% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

1.030.910.780.660.542025-09-122026-03-162026-09-11

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
0.53
S2
0.54
S1
0.55
PIVOT
0.56
R1
0.56
R2
0.57
R3
0.58

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
0.51 0.67
±14.25% from 0.59, made 2026-09-04 · resolves 2026-09-11
SELL
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 22590 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

STRONG SELL
19 indicators
OscillatorsSELL
2 buy · 2 neutral · 3 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)43.70NEUTRAL
Stochastic %K (14)11.11BUY
CCI (20)-92.89NEUTRAL
Williams %R (14)-88.89BUY
MACD (12,26,9)-0.00SELL
ROC (10)-6.67SELL
Momentum (10)-0.04SELL
EMA (10)0.57SELL
SMA (10)0.57SELL
EMA (20)0.58SELL
SMA (20)0.58SELL
EMA (30)0.58SELL
SMA (30)0.58SELL
EMA (50)0.59SELL
SMA (50)0.58SELL
EMA (100)0.63SELL
SMA (100)0.63SELL
EMA (200)0.72SELL
SMA (200)0.72SELL

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About CK Life Sciences Int'l., (Holdings) Inc.

Healthcare · Biotechnology

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, trades, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines; supplies raw materials in nutritional health, pharmaceutical, cosmetics, personal care and food segments; financing activities; holding land and buildings; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, the company distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; and produces, refines, and distributes salt products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; develops novel nonopioid therapeutics; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food sectors; and offers packing and asset management services. The company was founded in 1999 and is headquartered in Tai Po, Hong Kong.

ck-lifesciences.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

SMC — Top Down

Not enough price history yet for a smart-money structure read on any timeframe.

Momentum & Volume

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-08 · Asset managers net 912361 (-21819)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.